ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 138,38
-0,08%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Gritstone bio Inc (GRTS)

  7. Gritstone bio Inc (GRTS) Actualités

GRTS

Gritstone bio (GRTS)

Gritstone bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GRTS
DateHeureSourceTitreSymboleSociété
13/06/202413h00GlobeNewswire Inc.Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GRTSGritstone bio Inc
04/06/202422h05GlobeNewswire Inc.Gritstone bio to Participate in Upcoming Investor and Scientific ConferencesNASDAQ:GRTSGritstone bio Inc
18/05/202403h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRTSGritstone bio Inc
10/05/202422h06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GRTSGritstone bio Inc
09/05/202422h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRTSGritstone bio Inc
09/05/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTSGritstone bio Inc
09/05/202422h05GlobeNewswire Inc.Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:GRTSGritstone bio Inc
02/05/202422h05GlobeNewswire Inc.Gritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024NASDAQ:GRTSGritstone bio Inc
30/04/202413h00GlobeNewswire Inc.Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024NASDAQ:GRTSGritstone bio Inc
29/04/202413h00GlobeNewswire Inc.Gritstone bio Announces Appointment of Stephen Webster to its Board of DirectorsNASDAQ:GRTSGritstone bio Inc
15/04/202413h00GlobeNewswire Inc.Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)NASDAQ:GRTSGritstone bio Inc
08/04/202413h00GlobeNewswire Inc.Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024NASDAQ:GRTSGritstone bio Inc
02/04/202405h00GlobeNewswire Inc.Gritstone bio Announces Pricing of $32.5 Million Underwritten Public OfferingNASDAQ:GRTSGritstone bio Inc
01/04/202422h10GlobeNewswire Inc.Gritstone bio Announces Proposed Public OfferingNASDAQ:GRTSGritstone bio Inc
01/04/202422h01GlobeNewswire Inc.Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite StaNASDAQ:GRTSGritstone bio Inc
05/03/202422h39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GRTSGritstone bio Inc
05/03/202422h05GlobeNewswire Inc.Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:GRTSGritstone bio Inc
29/02/202422h05GlobeNewswire Inc.Gritstone bio Announces Workforce Reduction NASDAQ:GRTSGritstone bio Inc
13/02/202418h44Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GRTSGritstone bio Inc
12/02/202413h00GlobeNewswire Inc.Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical TrialNASDAQ:GRTSGritstone bio Inc
17/01/202413h00GlobeNewswire Inc.Gritstone bio to Participate in Upcoming Investor ConferenceNASDAQ:GRTSGritstone bio Inc
02/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GRTSGritstone bio Inc
22/12/202322h06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GRTSGritstone bio Inc
20/11/202313h00GlobeNewswire Inc.Gritstone bio to Participate in Upcoming Investor ConferencesNASDAQ:GRTSGritstone bio Inc
08/11/202322h05GlobeNewswire Inc.Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:GRTSGritstone bio Inc
12/10/202323h00GlobeNewswire Inc.Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio’s BARDA AwardNASDAQ:GRTSGritstone bio Inc
11/10/202313h10GlobeNewswire Inc.Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 VaccineNASDAQ:GRTSGritstone bio Inc
04/10/202322h05GlobeNewswire Inc.Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023NASDAQ:GRTSGritstone bio Inc
27/09/202322h01GlobeNewswire Inc.Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 MillionNASDAQ:GRTSGritstone bio Inc
15/08/202313h00GlobeNewswire Inc.Gritstone bio and Genevant Sciences Announce Option and License AgreementNASDAQ:GRTSGritstone bio Inc
 Showing the most relevant articles for your search:NASDAQ:GRTS

Dernières Valeurs Consultées

EU
CAP
Capgemini
EU
PX4
SBF 120
EU
HO
Thales
EU
LR
Legrand
EU
VK
Vallourec
NASDAQ
NVDA
NVIDIA
EU
SGO
Cie de SaintGobain
NASDAQ
AMZN
Amazon.com
EU
RI
Pernod Ricard
COIN
BTCUSD
Bitcoin
EU
MC
Lvmh Moet Hennessy Louis...
EU
ML
Michelin
NASDAQ
AAPL
Apple
EU
GLE
Societe Generale
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés